APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Patch

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Selected research

Market Outlook & Growth Opportunities

Global Transdermal Patch Market Outlook and Growth Opportunities 2026

21 December 2025208 pages

Choose your research edition.

Industry ResearchTransdermal Patch Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Patch Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Patch Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Patch Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patches are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others. Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%.

Transdermal Patches can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total.

Read the full market overview

Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019.

This report provides an overview of the global Transdermal Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Patch Segment by Company

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Grünenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy’s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical

Transdermal Patch Segment by Type

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Transdermal Patch Segment by Application

Rx Channel

OTC Channel

Transdermal Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transdermal Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transdermal Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transdermal Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Transdermal Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Patch industry.

Chapter 3: Detailed analysis of Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transdermal Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transdermal Patch Industry Trends Table 2. Transdermal Patch Industry Drivers Table 3. Transdermal Patch Industry Opportunities and Challenges Table 4. Transdermal Patch Industry Restraints Table 5. Global Transdermal Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transdermal Patch Revenue Share by Company (2021-2026) Table 7. Global Transdermal Patch Sales Volume by Company (M Pcs) & (2021-2026) Table 8. Global Transdermal Patch Sales Volume Share by Company (2021-2026) Table 9. Global Transdermal Patch Average Price (USD/Pc) of Company (2021-2026) Table 10. Global Transdermal Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transdermal Patch Key Company Manufacturing Base & Headquarters Table 12. Global Transdermal Patch Company, Product Type & Application Table 13. Global Transdermal Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Methyl Salicylate-based Patch Table 18. Significant Companies of Rivastigmine Transdermal Patch Table 19. Significant Companies of Fentanyl Transdermal Patch Table 20. Significant Companies of Lidocaine Patch Table 21. Significant Companies of Diclofenac Patch Table 22. Significant Companies of Nicotine Transdermal Patch Table 23. Significant Companies of Others Table 24. Global Transdermal Patch Sales Volume by Type 2021 VS 2025 VS 2032 (M Pcs) Table 25. Global Transdermal Patch Sales Volume by Type (2021-2026) & (M Pcs) Table 26. Global Transdermal Patch Sales Volume by Type (2027-2032) & (M Pcs) Table 27. Global Transdermal Patch Sales Volume Share by Type (2021-2026) Table 28. Global Transdermal Patch Sales Volume Share by Type (2027-2032) Table 29. Global Transdermal Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Transdermal Patch Sales Value by Type (2021-2026) & (US$ Million) Table 31. Global Transdermal Patch Sales Value by Type (2027-2032) & (US$ Million) Table 32. Global Transdermal Patch Sales Value Share by Type (2021-2026) Table 33. Global Transdermal Patch Sales Value Share by Type (2027-2032) Table 34. Significant Companies of Rx Channel Table 35. Significant Companies of OTC Channel Table 36. Global Transdermal Patch Sales Volume by Application 2021 VS 2025 VS 2032 (M Pcs) Table 37. Global Transdermal Patch Sales Volume by Application (2021-2026) & (M Pcs) Table 38. Global Transdermal Patch Sales Volume by Application (2027-2032) & (M Pcs) Table 39. Global Transdermal Patch Sales Volume Share by Application (2021-2026) Table 40. Global Transdermal Patch Sales Volume Share by Application (2027-2032) Table 41. Global Transdermal Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Transdermal Patch Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Transdermal Patch Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Transdermal Patch Sales Value Share by Application (2021-2026) Table 45. Global Transdermal Patch Sales Value Share by Application (2027-2032) Table 46. Global Transdermal Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 47. Global Transdermal Patch Sales by Region (2021-2026) & (M Pcs) Table 48. Global Transdermal Patch Sales Market Share by Region (2021-2026) Table 49. Global Transdermal Patch Sales by Region (2027-2032) & (M Pcs) Table 50. Global Transdermal Patch Sales Market Share by Region (2027-2032) Table 51. Global Transdermal Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Transdermal Patch Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Transdermal Patch Sales Value Share by Region (2021-2026) Table 54. Global Transdermal Patch Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Transdermal Patch Sales Value Share by Region (2027-2032) Table 56. Global Transdermal Patch Market Average Price (USD/Pc) by Region (2021-2026) Table 57. Global Transdermal Patch Market Average Price (USD/Pc) by Region (2027-2032) Table 58. Global Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 59. Global Transdermal Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Transdermal Patch Sales by Country (2021-2026) & (M Pcs) Table 61. Global Transdermal Patch Sales Market Share by Country (2021-2026) Table 62. Global Transdermal Patch Sales by Country (2027-2032) & (M Pcs) Table 63. Global Transdermal Patch Sales Market Share by Country (2027-2032) Table 64. Global Transdermal Patch Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Transdermal Patch Sales Value Market Share by Country (2021-2026) Table 66. Global Transdermal Patch Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Transdermal Patch Sales Value Market Share by Country (2027-2032) Table 68. Hisamitsu Pharmaceutical Company Information Table 69. Hisamitsu Pharmaceutical Business Overview Table 70. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 71. Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio Table 72. Hisamitsu Pharmaceutical Recent Development Table 73. Johnson & Johnson Company Information Table 74. Johnson & Johnson Business Overview Table 75. Johnson & Johnson Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 76. Johnson & Johnson Transdermal Patch Product Portfolio Table 77. Johnson & Johnson Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 81. Novartis Transdermal Patch Product Portfolio Table 82. Novartis Recent Development Table 83. UCB Pharma Company Information Table 84. UCB Pharma Business Overview Table 85. UCB Pharma Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 86. UCB Pharma Transdermal Patch Product Portfolio Table 87. UCB Pharma Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 91. Mylan Transdermal Patch Product Portfolio Table 92. Mylan Recent Development Table 93. Teva Pharmaceutical Company Information Table 94. Teva Pharmaceutical Business Overview Table 95. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Transdermal Patch Product Portfolio Table 97. Teva Pharmaceutical Recent Development Table 98. Nitto Denko Company Information Table 99. Nitto Denko Business Overview Table 100. Nitto Denko Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 101. Nitto Denko Transdermal Patch Product Portfolio Table 102. Nitto Denko Recent Development Table 103. Grünenthal Company Information Table 104. Grünenthal Business Overview Table 105. Grünenthal Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 106. Grünenthal Transdermal Patch Product Portfolio Table 107. Grünenthal Recent Development Table 108. IBSA Group Company Information Table 109. IBSA Group Business Overview Table 110. IBSA Group Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 111. IBSA Group Transdermal Patch Product Portfolio Table 112. IBSA Group Recent Development Table 113. GSK Company Information Table 114. GSK Business Overview Table 115. GSK Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 116. GSK Transdermal Patch Product Portfolio Table 117. GSK Recent Development Table 118. Luye Pharma Group Company Information Table 119. Luye Pharma Group Business Overview Table 120. Luye Pharma Group Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 121. Luye Pharma Group Transdermal Patch Product Portfolio Table 122. Luye Pharma Group Recent Development Table 123. Pfizer Company Information Table 124. Pfizer Business Overview Table 125. Pfizer Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 126. Pfizer Transdermal Patch Product Portfolio Table 127. Pfizer Recent Development Table 128. Chattem Company Information Table 129. Chattem Business Overview Table 130. Chattem Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 131. Chattem Transdermal Patch Product Portfolio Table 132. Chattem Recent Development Table 133. Dr Reddy’s Laboratories Company Information Table 134. Dr Reddy’s Laboratories Business Overview Table 135. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 136. Dr Reddy’s Laboratories Transdermal Patch Product Portfolio Table 137. Dr Reddy’s Laboratories Recent Development Table 138. Bayer Company Information Table 139. Bayer Business Overview Table 140. Bayer Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 141. Bayer Transdermal Patch Product Portfolio Table 142. Bayer Recent Development Table 143. Mundipharma Company Information Table 144. Mundipharma Business Overview Table 145. Mundipharma Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 146. Mundipharma Transdermal Patch Product Portfolio Table 147. Mundipharma Recent Development Table 148. Endo International Company Information Table 149. Endo International Business Overview Table 150. Endo International Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 151. Endo International Transdermal Patch Product Portfolio Table 152. Endo International Recent Development Table 153. Beijing Tide Pharmaceutical Company Information Table 154. Beijing Tide Pharmaceutical Business Overview Table 155. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Value (US$ Million), Price (USD/Pc) and Gross Margin (2021-2026) Table 156. Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio Table 157. Beijing Tide Pharmaceutical Recent Development Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Transdermal Patch Distributors List Table 161. Transdermal Patch Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Transdermal Patch Product Image Figure 2. Global Transdermal Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transdermal Patch Sales (2021-2032) & (M Pcs) Figure 5. Global Transdermal Patch Sales Average Price (USD/Pc) & (2021-2032) Figure 6. Global Transdermal Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methyl Salicylate-based Patch Image Figure 10. Rivastigmine Transdermal Patch Image Figure 11. Fentanyl Transdermal Patch Image Figure 12. Lidocaine Patch Image Figure 13. Diclofenac Patch Image Figure 14. Nicotine Transdermal Patch Image Figure 15. Others Image Figure 16. Global Transdermal Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 17. Global Transdermal Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 18. Global Transdermal Patch Sales Volume Share by Type (2021-2032) Figure 19. Global Transdermal Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Transdermal Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Transdermal Patch Sales Value Share by Type (2021-2032) Figure 22. Rx Channel Image Figure 23. OTC Channel Image Figure 24. Global Transdermal Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 25. Global Transdermal Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Transdermal Patch Sales Volume Share by Application (2021-2032) Figure 27. Global Transdermal Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Transdermal Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Transdermal Patch Sales Value Share by Application (2021-2032) Figure 30. Global Transdermal Patch Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Figure 31. Global Transdermal Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Transdermal Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Transdermal Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 35. North America Transdermal Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Transdermal Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Transdermal Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 41. South America Transdermal Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Transdermal Patch Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Transdermal Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Transdermal Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Transdermal Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Transdermal Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Transdermal Patch Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Transdermal Patch Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others
Applications
  • Rx Channel
  • OTC Channel
Companies covered
  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transdermal Patch Sales Value (2021-2032)
  4. 1.2.2 Global Transdermal Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Transdermal Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transdermal Patch Market Dynamics
  1. 2.1 Transdermal Patch Industry Trends
  2. 2.2 Transdermal Patch Industry Drivers
  3. 2.3 Transdermal Patch Industry Opportunities and Challenges
  4. 2.4 Transdermal Patch Industry Restraints
3 Transdermal Patch Market by Company
  1. 3.1 Global Transdermal Patch Company Revenue Ranking in 2025
  2. 3.2 Global Transdermal Patch Revenue by Company (2021-2026)
  3. 3.3 Global Transdermal Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Transdermal Patch Average Price by Company (2021-2026)
  5. 3.5 Global Transdermal Patch Company Ranking (2024-2026)
  6. 3.6 Global Transdermal Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Transdermal Patch Company Product Type and Application
  8. 3.8 Global Transdermal Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transdermal Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transdermal Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transdermal Patch Market by Type
  1. 4.1 Transdermal Patch Type Introduction
  2. 4.1.1 Methyl Salicylate-based Patch
  3. 4.1.2 Rivastigmine Transdermal Patch
  4. 4.1.3 Fentanyl Transdermal Patch
  5. 4.1.4 Lidocaine Patch
  6. 4.1.5 Diclofenac Patch
  7. 4.1.6 Nicotine Transdermal Patch
  8. 4.1.7 Others
  9. 4.2 Global Transdermal Patch Sales Volume by Type
  10. 4.2.1 Global Transdermal Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Transdermal Patch Sales Volume by Type (2021-2032)
  12. 4.2.3 Global Transdermal Patch Sales Volume Share by Type (2021-2032)
  13. 4.3 Global Transdermal Patch Sales Value by Type
  14. 4.3.1 Global Transdermal Patch Sales Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Transdermal Patch Sales Value by Type (2021-2032)
  16. 4.3.3 Global Transdermal Patch Sales Value Share by Type (2021-2032)
5 Transdermal Patch Market by Application
  1. 5.1 Transdermal Patch Application Introduction
  2. 5.1.1 Rx Channel
  3. 5.1.2 OTC Channel
  4. 5.2 Global Transdermal Patch Sales Volume by Application
  5. 5.2.1 Global Transdermal Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Transdermal Patch Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Transdermal Patch Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Transdermal Patch Sales Value by Application
  9. 5.3.1 Global Transdermal Patch Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Transdermal Patch Sales Value by Application (2021-2032)
  11. 5.3.3 Global Transdermal Patch Sales Value Share by Application (2021-2032)
6 Transdermal Patch Regional Sales and Value Analysis
  1. 6.1 Global Transdermal Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Transdermal Patch Sales by Region (2027-2032)
  5. 6.3 Global Transdermal Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transdermal Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transdermal Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transdermal Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Transdermal Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transdermal Patch Sales Value (2021-2032)
  12. 6.6.2 North America Transdermal Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transdermal Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Transdermal Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transdermal Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transdermal Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transdermal Patch Sales Value (2021-2032)
  21. 6.9.2 South America Transdermal Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transdermal Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transdermal Patch Sales Value Share by Country, 2025 VS 2032
7 Transdermal Patch Country-level Sales and Value Analysis
  1. 7.1 Global Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transdermal Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transdermal Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Transdermal Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Transdermal Patch Sales by Country (2027-2032)
  6. 7.4 Global Transdermal Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transdermal Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transdermal Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transdermal Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transdermal Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transdermal Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transdermal Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transdermal Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transdermal Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transdermal Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transdermal Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transdermal Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transdermal Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transdermal Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transdermal Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transdermal Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transdermal Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transdermal Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transdermal Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transdermal Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transdermal Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transdermal Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transdermal Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transdermal Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transdermal Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transdermal Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transdermal Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transdermal Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transdermal Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transdermal Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transdermal Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transdermal Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transdermal Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transdermal Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hisamitsu Pharmaceutical
  2. 8.1.1 Hisamitsu Pharmaceutical Company Information
  3. 8.1.2 Hisamitsu Pharmaceutical Business Overview
  4. 8.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Portfolio
  6. 8.1.5 Hisamitsu Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Transdermal Patch Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Transdermal Patch Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 UCB Pharma
  20. 8.4.1 UCB Pharma Company Information
  21. 8.4.2 UCB Pharma Business Overview
  22. 8.4.3 UCB Pharma Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 UCB Pharma Transdermal Patch Product Portfolio
  24. 8.4.5 UCB Pharma Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Transdermal Patch Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Teva Pharmaceutical
  32. 8.6.1 Teva Pharmaceutical Company Information
  33. 8.6.2 Teva Pharmaceutical Business Overview
  34. 8.6.3 Teva Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceutical Transdermal Patch Product Portfolio
  36. 8.6.5 Teva Pharmaceutical Recent Developments
  37. 8.7 Nitto Denko
  38. 8.7.1 Nitto Denko Company Information
  39. 8.7.2 Nitto Denko Business Overview
  40. 8.7.3 Nitto Denko Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nitto Denko Transdermal Patch Product Portfolio
  42. 8.7.5 Nitto Denko Recent Developments
  43. 8.8 Grünenthal
  44. 8.8.1 Grünenthal Company Information
  45. 8.8.2 Grünenthal Business Overview
  46. 8.8.3 Grünenthal Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Grünenthal Transdermal Patch Product Portfolio
  48. 8.8.5 Grünenthal Recent Developments
  49. 8.9 IBSA Group
  50. 8.9.1 IBSA Group Company Information
  51. 8.9.2 IBSA Group Business Overview
  52. 8.9.3 IBSA Group Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 IBSA Group Transdermal Patch Product Portfolio
  54. 8.9.5 IBSA Group Recent Developments
  55. 8.10 GSK
  56. 8.10.1 GSK Company Information
  57. 8.10.2 GSK Business Overview
  58. 8.10.3 GSK Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GSK Transdermal Patch Product Portfolio
  60. 8.10.5 GSK Recent Developments
  61. 8.11 Luye Pharma Group
  62. 8.11.1 Luye Pharma Group Company Information
  63. 8.11.2 Luye Pharma Group Business Overview
  64. 8.11.3 Luye Pharma Group Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Luye Pharma Group Transdermal Patch Product Portfolio
  66. 8.11.5 Luye Pharma Group Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Transdermal Patch Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Chattem
  74. 8.13.1 Chattem Company Information
  75. 8.13.2 Chattem Business Overview
  76. 8.13.3 Chattem Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chattem Transdermal Patch Product Portfolio
  78. 8.13.5 Chattem Recent Developments
  79. 8.14 Dr Reddy’s Laboratories
  80. 8.14.1 Dr Reddy’s Laboratories Company Information
  81. 8.14.2 Dr Reddy’s Laboratories Business Overview
  82. 8.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Portfolio
  84. 8.14.5 Dr Reddy’s Laboratories Recent Developments
  85. 8.15 Bayer
  86. 8.15.1 Bayer Company Information
  87. 8.15.2 Bayer Business Overview
  88. 8.15.3 Bayer Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bayer Transdermal Patch Product Portfolio
  90. 8.15.5 Bayer Recent Developments
  91. 8.16 Mundipharma
  92. 8.16.1 Mundipharma Company Information
  93. 8.16.2 Mundipharma Business Overview
  94. 8.16.3 Mundipharma Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Mundipharma Transdermal Patch Product Portfolio
  96. 8.16.5 Mundipharma Recent Developments
  97. 8.17 Endo International
  98. 8.17.1 Endo International Company Information
  99. 8.17.2 Endo International Business Overview
  100. 8.17.3 Endo International Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Endo International Transdermal Patch Product Portfolio
  102. 8.17.5 Endo International Recent Developments
  103. 8.18 Beijing Tide Pharmaceutical
  104. 8.18.1 Beijing Tide Pharmaceutical Company Information
  105. 8.18.2 Beijing Tide Pharmaceutical Business Overview
  106. 8.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Portfolio
  108. 8.18.5 Beijing Tide Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Patch Value Chain Analysis
  2. 9.1.1 Transdermal Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Patch Sales Mode & Process
  6. 9.2 Transdermal Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Patch Distributors
  9. 9.2.3 Transdermal Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst